whatshot

IRWD   $3.04  -5.88% Market Closed After Close 3.2397 6.57%

Ironwood Pharmaceuticals, Inc.
show_chart Advanced Chart of IRWD
Last Events:

2023-08-09 Trend changed from turning down to flat and down.

2023-08-06 Signal in RSI changed from bullish weakening to bullish recovery. RSI indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: entrance to the overbought zone.

2023-08-05 Trend pattern changed from нисходящий треугольник to сужающийся канал.

2023-08-05 Signal in Stochastic changed from bullish weakening to bearish reversal. The stochastic indicator is in the upper part of the neutral territory and left the overbought territory. These factors indicate that perhaps the upside trend is coming to an end price will probably head south Last signal: exit from the overbought zone.

2023-08-04 Signal in Stochastic changed from bullish recovery to bullish weakening. The stochastic indicator is in overbought territory and it heading south. These factors indicate that perhaps the upside trend is coming to an end. Last signal: main and signal line crossing.

2023-08-04 Signal in RSI changed from bullish to bullish weakening. RSI indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: entrance to the overbought zone.

2023-08-02 Trend Power changed from medium strength to almost flat.

2023-08-02 Trend changed from flat and down to turning down.

Current temperature: 16.73
ST: 0, Cor:

50-50 Year Forecast
Low with % probability:
Target: 2.82
High with % probability:
Analyst Recommendations:
Number of estimates 4
Target Price Mean 5.35
Mean unverified/preliminary 5.35 / 5.35
Target Price Low / High 0.70 / 10.00
Median / STD DEV 5.35 / 3.81
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total None None Sell
rsi ActivelyBuy None Sell
macd None None None
stoch None None None
ma20 ActivelyBuy ActivelyBuy None
ma50 None None None
ma100 None None Sell
Candlestick PatternMarch 3, 2026 Bullish Three Outside Up - pattern is a made up of three candlesticks. A black candlestick appears on the first day in a downtrend. The second day body engulfs the black body of the first day. A white candlestick on the third day with a higher closethan the second day. Considered to be a bullish reversal pattern.
ISIN US46333X1081
ceo Mr. Thomas A. McCourt
Website https://www.ironwoodpharma.com
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation under the LINZESS name in the United States, Mexico, Japan, Saudi Arabia, and China, as well as under the CONSTELLA name in the Canada and European countries. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; Apraglutide, a next-generation, long-acting synthetic peptide analog of glucagon-like peptide-2, as a differentiated therapeutic for rare diseases, including short bowel syndrome dependent on parenteral support and acute graft versus host disease; and CNP-104, an immune nanoparticle for the treatment of primary biliary cholangitis. The company has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.